Development and validation of an optimal GATE model for proton pencil-beam scanning delivery.

AAPM TG-119 Monte Carlo simulation Proton therapy active scanning prostate

Journal

Zeitschrift fur medizinische Physik
ISSN: 1876-4436
Titre abrégé: Z Med Phys
Pays: Germany
ID NLM: 100886455

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 10 12 2021
revised: 14 10 2022
accepted: 14 10 2022
pubmed: 25 11 2022
medline: 25 11 2022
entrez: 24 11 2022
Statut: ppublish

Résumé

To develop and validate a versatile Monte Carlo (MC)-based dose calculation engine to support MC-based dose verification of treatment planning systems (TPSs) and quality assurance (QA) workflows in proton therapy. The GATE MC toolkit was used to simulate a fixed horizontal active scan-based proton beam delivery (SIEMENS IONTRIS). Within the nozzle, two primary and secondary dose monitors have been designed to enable the comparison of the accuracy of dose estimation from MC simulations with respect to physical QA measurements. The developed beam model was validated against a series of commissioning measurements using pinpoint chambers and 2D array ionization chambers (IC) in terms of lateral profiles and depth dose distributions. Furthermore, beam delivery module and treatment planning has been validated against the literature deploying various clinical test cases of the AAPM TG-119 (c-shape phantom) and a prostate patient. MC simulations showed excellent agreement with measurements in the lateral depth-dose parameters and spread-out Bragg peak (SOBP) characteristics within a maximum relative error of 0.95 mm in range, 1.83% in entrance to peak ratio, 0.27% in mean point-to-point dose difference, and 0.32% in peak location. The mean relative absolute difference between MC simulations and measurements in terms of absorbed dose in the SOBP region was 0.93% ± 0.88%. Clinical phantom studies showed a good agreement compared to research TPS (relative error for TG-119 planning target volume PTV-D We successfully developed a MC model for the pencil beam scanning system, which appears reliable for dose verification of the TPS in combination with QA information, prior to patient treatment.

Identifiants

pubmed: 36424313
pii: S0939-3889(22)00102-7
doi: 10.1016/j.zemedi.2022.10.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-600

Informations de copyright

Copyright © 2022. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ali Asadi (A)

Department of Energy Engineering, Sharif University of Technology, Tehran, Iran.

Azadeh Akhavanallaf (A)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland.

Seyed Abolfazl Hosseini (SA)

Department of Energy Engineering, Sharif University of Technology, Tehran, Iran. Electronic address: sahosseini@sharif.edu.

Naser Vosoughi (N)

Department of Energy Engineering, Sharif University of Technology, Tehran, Iran.

Habib Zaidi (H)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland; Geneva University Neurocenter, Geneva University, Geneva, Switzerland; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Nuclear Medicine, University of Southern Denmark, Odense, Denmark. Electronic address: habib.zaidi@hcuge.ch.

Classifications MeSH